Evidence mapPaperPMID 39703045Full record

ReviewMolecular nutrition & food research2025

The Neuroprotective Effect of Rooibos Herbal Tea Against Alzheimer's Disease: A Review.

Elias Chipofya, Taskeen F Docrat, Jeanine L Marnewick

Abstract readReview
In one paragraph

Review in Molecular nutrition & food research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elias ChipofyaApplied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Cape Town, South Africa.
Taskeen F DocratApplied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Cape Town, South Africa.ORCID 0000-0003-2468-6054
Jeanine L MarnewickApplied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Cape Town, South Africa.

Funding

Cape Peninsula University of TechnologySouth African Rooibos Council
6 · The paper itself

Abstract

The world is experiencing a demographic shift toward an increasing proportion of elderly persons. Alzheimer's disease (AD) and other neurological disorders are far more likely to develop as people age. AD is a gradual, irreversible, and degenerative brain disorder that progressively deteriorates memory and cognitive function, eventually leading to death. Treatment for AD is the most significant unmet clinical need in neurology. There are no effective treatment options to prevent or reverse the degenerative process. The current medical management focuses primarily on temporarily easing symptoms, with little or no overall improvement. Although genetic predisposition and lifestyle factors influence the risk of neurodegenerative disorders, recent research suggests that dietary polyphenols with solid antioxidant capacities play crucial roles in determining brain health and aging. Aspalathus linearis is used to produce Rooibos, a popular South African herbal tea, which may modulate neurodegenerative mechanisms such as oxidative stress, tau protein, amyloid plaques, inflammation, and metals, all of which have been associated with AD. We reviewed the literature to evaluate the potential neuroprotective effects of Rooibos and its major flavonoids and to understand the underlying molecular mechanisms.

Indexed as

Alzheimer DiseaseAspalathusNeuroprotective AgentsOxidative StressTeas, HerbalAnimalsAntioxidantsFlavonoidsHumansPlant ExtractsPolyphenolstau ProteinsAntioxidantsFlavonoidsNeuroprotective AgentsPlant ExtractsPolyphenolstau ProteinsTeas, HerbalAlzheimer's diseaseneurodegenerative disordersneuroprotectionRooibos

Identifiers

PMID39703045
PMCPMC11704843

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.